Samsung Medical Center announced that its researchers have developed a new AI model capable of predicting the recurrence risk of non-small cell lung cancer up to a year in advance. According to the ...

An artificial intelligence (AI) that predicts the recurrence risk of non-small cell lung cancer patients one year in advance has been developed. Non-small cell lung cancer refers to the large type of ...

Real-world effectiveness of first-line chemo-immunotherapy and chemotherapy on ES-SCLC: A propensity score-matched study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Despite recommendations for posttreatment surveillance in lung cancer patients, there is wide variability in the follow-up care that lung cancer patients receive. A recent study, led by senior author ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...

Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

In patients with high PD-L1 expression identified before surgery, clinicians should consider the possibility of lymph node metastasis when determining surgical strategy, including the extent of lymph ...